Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Auckland DHB clinical researchers awarded $2.7m

Auckland DHB clinical researchers awarded $2.7m

Researchers at the Auckland DHB have received $2.7 million of funding this week in the latest Health Research Council funding round for a range of groundbreaking projects.

These are:

• A pioneering investigation into the causes of the most severe form of epilepsy Status Epilepticus in the greater Auckland region led by neurologist r Peter Bergin ($671,183)

• The New Zealand contribution to the largest international trial of sedation in critically ill patients that will determine the better of two current sedative options for patients on ventilators led by critical care specialist Dr Colin McArthur

($1,118,621)

• A trial to determine the optimum level of intravenous fluid with potential impacts on the 250 million people a year worldwide who undergo major surgery led by cardiovascular intensive care specialist Dr Shay McGuinness study ($770,668)

Auckland DHB Chief Executive Ailsa Claire said the grants showed the value the country’s research community placed on the work of clinical research teams at Auckland City Hospital and the Greenlane Clinical Centre.

“These clinicians are on the frontline of delivering excellence in health care. Their research is firmly focused on how to do better for our patients. They deserve warm congratulations.”

She said that Auckland City Hospital clinicians had a 100 per cent success rate with their full applications in this round, which showed recognition of the potential global impact and value of the research.

In addition to the three successful major project grants, Auckland City hospital clinicians were successful with applications for funding for two feasibility studies that are the interim stage for major research projects.

Dr Shay McGuinness will lead a study of how the control of oxygen levels during
heart bypass surgery can improve patient outcomes. ($141,411)


ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Royal Society: Review Finds Community Water Fluoridation Safe And Effective

A review of the scientific evidence for and against the efficacy and safety of fluoridation of public water supplies has found that the levels of fluoridation used in New Zealand create no health risks and provide protection against tooth decay. More>>

ALSO:

Scoop Business: Croxley Calls Time On NZ Production In Face Of Cheap Imports

Croxley Stationery, whose stationery brands include Olympic, Warwick and Collins, plans to cease manufacturing in New Zealand because it has struggled to compete with lower-cost imports in a market where the printed word is giving way to electronic communications. More>>

ALSO:

Prefu Roundup: Forecasts Revised, Surplus Intact

The National government heads into the election with its Budget surplus target broadly intact, delivering a set of economic and fiscal forecasts marginally revised from May to reflect weaker commodity prices and a lower tax take. More>>

ALSO:

Convention Centre: Major New SkyCity Hotel And Laneway For Auckland

Today SKYCITY Entertainment Group Limited revealed plans to build a new hotel and pedestrian laneway of bars, restaurants and boutique shopping on land it owns in the Nelson and Hobson Streets block, expanding the SKYCITY Entertainment Precinct. More>>

ALSO:

Igniting The Spark: Bringing The Digital Enabler To Life

Changing a name is, relatively speaking, the easy part of a re-invention. Changing a culture, getting all the ducks in a row, turning yourself inside-out to become customer-inspired is a much bigger challenge. More>>

ALSO:

Ebola And NZ: Targeted Screening At Airport But Risk Low

The risk of any cases of Ebola in New Zealand remains very low, but health and border authorities are well prepared... anyone arriving in New Zealand who in the last three weeks has visited countries affected will be screened for symptoms of the disease. More>>

ALSO:

Scoop Business: Brewer Seeking Crowd-Funding Cancels Shareholders’ Dividends

Shareholders in Renaissance Brewing company, the first business to seek equity through crowd-funding in New Zealand, have cancelled their claim on $147,000 of accumulated earnings “to make Renaissance a more attractive investment opportunity.” More>>

ALSO:

Get More From Scoop

 
 
Computer Power Plus

Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news